Long-term treatment with rituximab — a cancer drug used despite not having specific approval — is safe and generally effective for controlling IgG4-related disease (IgG4-RD), though researchers say more study is needed to standardize its use. Those are the outcomes of a small study by scientists in Germany, who…
Discussion
My name is Silvia Borgers, and I live in the Netherlands with my husband, our dog, and our cat. Our children have left home, but thankfully, we still see them often. That is the advantage of living in a small country like the Netherlands. My lovely family has been my…
Most adults ages 50 and older with immunoglobulin G4-related disease (IgG4-RD) have multiple organ involvement, whereas the disease predominantly affects a single organ in patients ages 25 years or younger, according to a study in Argentina. Data also showed that older patients had more pronounced involvement of lymph…
Get regular updates to your inbox.
